Literature DB >> 28627454

Synthesis, physiochemical characterization, and in vitro antitumor activity of the amide and pH cleavable hydrazone conjugates of γ-tocotrienol isomer of vitamin E with methoxy-poly(ethylene) glycol.

Ahmed Abu-Fayyad1, Sami Nazzal2.   

Abstract

The anticancer activity of n class="Chemical">water soluble methoxy polyethylene glycol (mPEG) derivatives of tocotrienol (T3) isomers of vitamin E was previously found to be reduced when compared to the parent free isomers. This could be due to the ester bond formation between the mPEG and the 6-OH group on the chroman moiety of the T3 isomer. To further investigate, the objectives of the current study were to (1) synthesize and characterize stable amide and cleavable hydrazone conjugates between mPEG and carbon-5 on the chroman moiety of T3, and (2) examine the cytotoxicity of the newly synthesized mPEG conjugates against breast (MCF-7 and MDA-MB-231) and pancreatic (BxPC-3 and PANC-1) cancer cells. Conjugates were synthesized by direct conjugation of succinyl chloride derivatives of mPEG to the α-tocopherol and γ-tocotrienol isomers of vitamin E, and were characterized by 1H NMR, FT-IR, and mass spectrometry. The micelles of the amide and hydrazone self-assembled conjugates were characterized for size, zeta, CMC, and stability at different pH media. The hydrolysis of the hydrazone conjugate was pH dependent with highest release at acidic (pH 5.5) conditions, whereas the amide conjugate was stable in all tested media. The amide conjugate nonetheless showed greater cytotoxicity than the hydrazone conjugate, which suggested that maintaining solubility and the presence of free 6-OH group are important for γ-T3 to exert anticancer activity in vitro. The results from the current study demonstrated the importance of considering the nature of the chemical bond between T3 and mPEG when designing functional ingredients for use in drug delivery.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acid-degradation; Cancer chemotherapy; Drug delivery; Hydrazone; Nanotechnology; PEGylation; Tocopherol; Tocotrienol; Vitamin E

Mesh:

Substances:

Year:  2017        PMID: 28627454      PMCID: PMC5557666          DOI: 10.1016/j.ijpharm.2017.06.033

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  19 in total

1.  {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.

Authors:  Ajaikumar B Kunnumakkara; Bokyung Sung; Jayaraj Ravindran; Parmeswaran Diagaradjane; Amit Deorukhkar; Sanjit Dey; Cemile Koca; Vivek R Yadav; Zhimin Tong; Juri G Gelovani; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2010-09-23       Impact factor: 12.701

2.  Lysosomal delivery of a lipophilic gemcitabine prodrug using novel acid-sensitive micelles improved its antitumor activity.

Authors:  Saijie Zhu; Dharmika S P Lansakara-P; Xinran Li; Zhengrong Cui
Journal:  Bioconjug Chem       Date:  2012-04-18       Impact factor: 4.774

Review 3.  Tocotrienols: Vitamin E beyond tocopherols.

Authors:  Chandan K Sen; Savita Khanna; Sashwati Roy
Journal:  Life Sci       Date:  2006-02-03       Impact factor: 5.037

Review 4.  Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.

Authors:  Bharat B Aggarwal; Chitra Sundaram; Seema Prasad; Ramaswamy Kannappan
Journal:  Biochem Pharmacol       Date:  2010-08-07       Impact factor: 5.858

Review 5.  Phenotype and genotype of pancreatic cancer cell lines.

Authors:  Emily L Deer; Jessica González-Hernández; Jill D Coursen; Jill E Shea; Josephat Ngatia; Courtney L Scaife; Matthew A Firpo; Sean J Mulvihill
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

Review 6.  Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions.

Authors:  Roland Andersson; Ursula Aho; Bo I Nilsson; Godefridus J Peters; Marçal Pastor-Anglada; Wenche Rasch; Marit L Sandvold
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

7.  Polymeric micelle for tumor pH and folate-mediated targeting.

Authors:  Eun Seong Lee; Kun Na; You Han Bae
Journal:  J Control Release       Date:  2003-08-28       Impact factor: 9.776

8.  d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells.

Authors:  Deema Hussein; Huanbiao Mo
Journal:  Pancreas       Date:  2009-05       Impact factor: 3.327

9.  PEGylated γ-tocotrienol isomer of vitamin E: Synthesis, characterization, in vitro cytotoxicity, and oral bioavailability.

Authors:  Ahmed Abu-Fayyad; Fathy Behery; Asmaa A Sallam; Saeed Alqahtani; Hassan Ebrahim; Khalid A El Sayed; Amal Kaddoumi; Paul W Sylvester; Jennifer L Carroll; James A Cardelli; Sami Nazzal
Journal:  Eur J Pharm Biopharm       Date:  2015-07-30       Impact factor: 5.571

10.  Antiproliferative effects of γ-tocotrienol are associated with lipid raft disruption in HER2-positive human breast cancer cells.

Authors:  Osama A Alawin; Rayan A Ahmed; Baher A Ibrahim; Karen P Briski; Paul W Sylvester
Journal:  J Nutr Biochem       Date:  2015-10-23       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.